{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:38:49Z","timestamp":1794353929937,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117908","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T19:40:00Z","timestamp":1739043600000},"page":"117908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: \u0391 factorial dose-escalation study"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-9674","authenticated-orcid":false,"given":"Klemens","family":"Egger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Jare\u00f1o Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovin","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Dornbierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7348-5115","authenticated-orcid":false,"given":"John","family":"Smallridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5915-7086","authenticated-orcid":false,"given":"Helena D.","family":"Aicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-5431","authenticated-orcid":false,"given":"Daniel","family":"Meling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8331-5282","authenticated-orcid":false,"given":"Jonas","family":"Kost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-2774","authenticated-orcid":false,"given":"Maxim","family":"Puchkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"\u00c4bel\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7933-2865","authenticated-orcid":false,"given":"Boris B.","family":"Quednow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4087-3650","authenticated-orcid":false,"given":"Robin","family":"von Rotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Scheidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario A.","family":"Dornbierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117908_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002130000606","article-title":"Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers","volume":"154","author":"Riba","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2025.117908_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","article-title":"Ayahuasca: pharmacology, neuroscience and therapeutic potential","volume":"126","author":"Dominguez-Clave","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2025.117908_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","article-title":"Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca","volume":"10","author":"McKenna","year":"1984","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2025.117908_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/02791072.2020.1815911","article-title":"Chemical composition of traditional and analog Ayahuasca","volume":"53","author":"Kaasik","year":"2021","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.biopha.2025.117908_bib5","first-page":"1","article-title":"Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors","volume":"81","author":"Egger","year":"2024","journal-title":"Cell. Mol. Life Sci. 2024"},{"key":"10.1016\/j.biopha.2025.117908_bib6","series-title":"Ayahuasca Healing and Science","author":"Labate","year":"2021"},{"key":"10.1016\/j.biopha.2025.117908_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/anoc.12056","article-title":"The globalization of Ayahuasca Shamanism and the Erasure of indigenous shamanism","volume":"27","author":"Fotiou","year":"2016","journal-title":"Anthr. Conscious"},{"key":"10.1016\/j.biopha.2025.117908_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000438","article-title":"Adverse effects of ayahuasca: results from the Global Ayahuasca Survey","volume":"2","author":"Bouso","year":"2022","journal-title":"PLOS Glob. Public Health"},{"key":"10.1016\/j.biopha.2025.117908_bib9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1055\/a-1675-3840","article-title":"Beyond the psychoactive effects of Ayahuasca: cultural and pharmacological relevance of its emetic and purging properties","volume":"88","author":"Politi","year":"2022","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2025.117908_bib10","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/0006-2952(79)90695-6","article-title":"Oxidation of p-, m- and o-tyramine by type A and type B monoamine oxidase","volume":"28","author":"Suzuki","year":"1979","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.117908_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-8741(98)00168-8","article-title":"Pharmacokinetics of Hoasca alkaloids in healthy humans","volume":"65","author":"Callaway","year":"1999","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2025.117908_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00005053-199602000-00004","article-title":"Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil","volume":"184","author":"Grob","year":"1996","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.biopha.2025.117908_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1246892","article-title":"Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine","volume":"14","author":"Dornbierer","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.117908_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/dta.1685","article-title":"Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study","volume":"7","author":"Riba","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.biopha.2025.117908_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41398-023-02477-4","article-title":"Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants","volume":"13","author":"Vogt","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117908_bib16","article-title":"Psychological and physiological effects of extended DMT","author":"Luan","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.117908_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13318-023-00822-y","article-title":"Pharmacokinetics of N,N-dimethyltryptamine in Humans","volume":"48","author":"Good","year":"2023","journal-title":"Eur. J. Drug Metab. Pharm."},{"key":"10.1016\/j.biopha.2025.117908_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1302559","article-title":"Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects","volume":"14","author":"Aicher","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopha.2025.117908_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(98)00154-9","article-title":"Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture","volume":"54","author":"Freedland","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.biopha.2025.117908_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202303333","article-title":"Calcium phosphate microcapsules as multifunctional drug delivery devices","volume":"33","author":"Kost","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.biopha.2025.117908_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopha.2025.117908_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.049882","article-title":"Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics","volume":"306","author":"Riba","year":"2003","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.117908_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13659-019-0210-5","article-title":"Ayahuasca: uses, phytochemical and biological activities","volume":"9","author":"Estrella-Parra","year":"2019","journal-title":"Nat. Prod. Bioprospect"},{"key":"10.1016\/j.biopha.2025.117908_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/plants9070870","article-title":"Biodiversity of \u03b2-carboline profile of banisteriopsis caapi and ayahuasca, a plant and a brew with neuropharmacological potential","volume":"9","author":"Santos","year":"2020","journal-title":"Plants"},{"key":"10.1016\/j.biopha.2025.117908_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1140656","article-title":"A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine","volume":"14","author":"Egger","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.117908_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ph13110334","article-title":"Toxicokinetics and toxicodynamics of Ayahuasca Alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact","volume":"13","author":"Brito-da-Costa","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.biopha.2025.117908_bib27","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.4088\/JCP.08m05041blu","article-title":"Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors","volume":"70","author":"Shulman","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117908_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/02791072.2005.10399797","article-title":"Fast and slow metabolizers of Hoasca","volume":"37","author":"Callaway","year":"2005","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.biopha.2025.117908_bib29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.117908_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.886408","article-title":"Monoamine oxidase inhibition by plant-derived \u03b2-carbolines; implications for the psychopharmacology of tobacco and Ayahuasca","volume":"13","author":"Berlowitz","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.117908_bib31","first-page":"214","article-title":"Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide","volume":"18","author":"Nair","year":"1993","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.biopha.2025.117908_bib32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s43440-023-00539-4","article-title":"Cardiovascular safety of psychedelic medicine: current status and future directions","volume":"75","author":"Ws\u00f3\u0142","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2025.117908_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.117908_bib34","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, the clinical evaluation of qt\/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, \u3008Https:\/\/Database.Ich.Org\/Sites\/Default\/Files\/E14_Guideline.Pdf\u3009 (2005)."},{"key":"10.1016\/j.biopha.2025.117908_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/02698811241273772","article-title":"A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers","author":"Ables","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.117908_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11916-010-0119-5","article-title":"Fasting headache","volume":"14","author":"Torelli","year":"2010","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.biopha.2025.117908_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000026514","article-title":"Acute and chronic effects of caffeine on performance, mood, headache, and sleep","volume":"38","author":"James","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopha.2025.117908_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11916-008-0052-z","article-title":"Caffeine and headaches","volume":"12","author":"Shapiro","year":"2008","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.biopha.2025.117908_bib39","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","article-title":"Pharmacology of ayahuasca administered in two repeated doses","volume":"219","author":"Dos Santos","year":"2012","journal-title":"Psychopharmacology (Berl. )"},{"key":"10.1016\/j.biopha.2025.117908_bib40","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1111\/cts.13410","article-title":"Population pharmacokinetic\/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine \u2013 Implications for dose considerations","volume":"15","author":"Eckern\u00e4s","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.biopha.2025.117908_bib41","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1162\/jocn_a_02003","article-title":"Altered state of consciousness and mental imagery as a function of N, N -dimethyltryptamine concentration in ritualistic ayahuasca users","volume":"35","author":"Ramaekers","year":"2023","journal-title":"J. Cogn. Neurosci."},{"key":"10.1016\/j.biopha.2025.117908_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.22181","article-title":"Interrupting the psychedelic experience through contextual manipulation to study experience efficacy","volume":"7","author":"Roseman","year":"2024","journal-title":"JAMA Netw. Open"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T23:45:01Z","timestamp":1741045501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"alternative-id":["S0753332225001027"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117908","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: \u0391 factorial dose-escalation study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117908"}}